Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia - PubMed
Kemal Agbaht 1 ,
Article ImagesComparative Study
Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia
Kemal Agbaht et al. Crit Care Med. 2007 Sep.
Abstract
Objective: To assess whether bacteremic ventilator-associated pneumonia (B-VAP) differs in terms of risk factors, organisms, and outcomes from nonbacteremic VAP (NB-VAP).
Design: A retrospective, single-center, observational, cohort study.
Setting: Multidisciplinary teaching intensive care unit.
Patients: Adult patients requiring mechanical ventilation, identified as having VAP in a 44-month prospective surveillance database.
Interventions: Each B-VAP patient was matched with two controls with VAP and negative blood cultures based on the microbial etiology responsible for VAP, Acute Physiology and Chronic Health Evaluation II score on admission (+/-3 points), diagnostic category, and length of stay before pneumonia onset.
Measurements and main results: B-VAP was documented in 35 (17.6%) of 199 microbiologically confirmed VAP episodes. B-VAP developed later (median 8 vs. 5 days, p = .03) and was more frequent in previously hospitalized patients (34.3% vs. 11.0%, p < .01) and in older patients (57.4 +/- 15.2 vs. 49.5 +/- 19.3 yrs, p = .02). B-VAP was more often caused by methicillin-resistant Staphylococcus aureus (12 [20.7%] vs. 13 [5.1%] episodes, p < .01), whereas Haemophilus influenzae was associated with NB-VAP (52 [20.4%] vs. 0, p < .01). Multivariate analysis confirmed an association between B-VAP and both methicillin-resistant S. aureus (odds ratio 3.18; 95% confidence interval 1.15-8.76, p < .01) and prior hospitalization (odds ratio 2.56; 95% confidence interval 1.01-6.54, p = .05). After adjustment for potential confounders, B-VAP (hazard ratio for death 2.55; 95% confidence interval 1.25-5.23, p = .01) and vasopressor use (hazard ratio 2.43; 95% confidence interval 1.23-4.82, p = .01) remained associated with mortality. The estimated relative risk of death for bacteremic cases was 2.86 (95% confidence interval 1.09-7.51), since mortality for cases and matched NB-VAP controls was 40.6% (13 of 32) and 19.3% (11 of 57), respectively.
Conclusions: B-VAP occurs later during intensive care unit stay, is more frequent in previously hospitalized patients, is more often caused by methicillin-resistant S. aureus, and is independently associated with increased intensive care unit mortality.
Comment in
-
Schultz MJ, Spronk PE. Schultz MJ, et al. Crit Care Med. 2007 Sep;35(9):2215-6. doi: 10.1097/01.CCM.0000281520.94595.C7. Crit Care Med. 2007. PMID: 17713371 No abstract available.
Similar articles
-
Shorr AF, Combes A, Kollef MH, Chastre J. Shorr AF, et al. Crit Care Med. 2006 Mar;34(3):700-6. doi: 10.1097/01.CCM.0000201885.57697.21. Crit Care Med. 2006. PMID: 16505656
-
Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J. Combes A, et al. Crit Care Med. 2007 Jan;35(1):146-54. doi: 10.1097/01.CCM.0000249826.81273.E4. Crit Care Med. 2007. PMID: 17080004
-
Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J, Diaz E, Topeli A, DeWaele J, Carneiro A, Martin-Loeches I, Armaganidis A, Rello J; EU-VAP/CAP Study Group. Koulenti D, et al. Crit Care Med. 2009 Aug;37(8):2360-8. doi: 10.1097/CCM.0b013e3181a037ac. Crit Care Med. 2009. PMID: 19531951
-
Eagye KJ, Nicolau DP, Kuti JL. Eagye KJ, et al. Semin Respir Crit Care Med. 2009 Feb;30(1):116-23. doi: 10.1055/s-0028-1119815. Epub 2009 Feb 6. Semin Respir Crit Care Med. 2009. PMID: 19199193 Review.
-
The impact of ventilator-associated pneumonia on the Canadian health care system.
Muscedere JG, Martin CM, Heyland DK. Muscedere JG, et al. J Crit Care. 2008 Mar;23(1):5-10. doi: 10.1016/j.jcrc.2007.11.012. J Crit Care. 2008. PMID: 18359415 Review.
Cited by
-
Andrianopoulos I, Kazakos N, Lagos N, Maniatopoulou T, Papathanasiou A, Papathanakos G, Koulenti D, Toli E, Gartzonika K, Koulouras V. Andrianopoulos I, et al. Antibiotics (Basel). 2024 Feb 8;13(2):169. doi: 10.3390/antibiotics13020169. Antibiotics (Basel). 2024. PMID: 38391555 Free PMC article.
-
Role of multidrug-resistant bacteria in weaning from invasive mechanical ventilation.
Michels-Zetsche JD, Gassmann V, Jasuja JK, Neetz B, Höger P, Meis J, Britsch S, Sommerwerck U, Fähndrich S, Bornitz F, Müller MM, Herth FJF, Trudzinski FC. Michels-Zetsche JD, et al. Respir Res. 2024 Feb 5;25(1):69. doi: 10.1186/s12931-024-02694-5. Respir Res. 2024. PMID: 38317197 Free PMC article.
-
Martin-Loeches I, Shorr AF, Kollef MH, Du J, Losada MC, Paschke A, DeRyke CA, Wong M, Jensen EH, Chen LF. Martin-Loeches I, et al. Open Forum Infect Dis. 2023 May 4;10(6):ofad225. doi: 10.1093/ofid/ofad225. eCollection 2023 Jun. Open Forum Infect Dis. 2023. PMID: 37383243 Free PMC article.
-
Gouel-Cheron A, Swihart BJ, Warner S, Mathew L, Strich JR, Mancera A, Follmann D, Kadri SS. Gouel-Cheron A, et al. Crit Care Med. 2022 Dec 1;50(12):1725-1736. doi: 10.1097/CCM.0000000000005662. Epub 2022 Oct 3. Crit Care Med. 2022. PMID: 36190259 Free PMC article.
-
Gago J, Filardo TD, Conderino S, Magaziner SJ, Dubrovskaya Y, Inglima K, Iturrate E, Pironti A, Schluter J, Cadwell K, Hochman S, Li H, Torres VJ, Thorpe LE, Shopsin B. Gago J, et al. Open Forum Infect Dis. 2022 Apr 5;9(6):ofac083. doi: 10.1093/ofid/ofac083. eCollection 2022 Jun. Open Forum Infect Dis. 2022. PMID: 35607701 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources